International Drug Development Institute Usa Inc - Cambridge, Massachusetts 02138

International Drug Development Institute Usa Inc is categorized under Marketing Consultants in Cambridge, MA .

Business Name: International Drug Development Institute Usa Inc
Contact Person: Dr Marc Buyse
Address: 185 Alewife Brook Parkway # 41, Cambridge, Massachusetts 02138
Phone Number: (617) 349-3600
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Marketing Consultants
SIC Code: 8742
NAICS Code: 541613
Share This Business:
Related Businesses: Blackbox Mktg - Cambridge, MA 02138
Aviant Media - Cambridge, MA 02138
C Graham Hurlbut Harvard Univ - Cambridge, MA 02138
Asa Inc - Cambridge, MA 02138
Wpi Inc - Cambridge, MA 02138
Advantage Technical Mktg - Cambridge, MA 02138
Eligus Group - Cambridge, MA 02138
Nolan Group - Cambridge, MA 02138
Image Ink - Cambridge, MA 02138
Harvard Student Resources - Cambridge, MA 02138
Carol Uhlnordlinger - Cambridge, MA 02138
Bredin - Cambridge, MA 02138
TribalVision - Cambridge, MA 02138

The company International Drug Development Institute Usa Inc provides B2B services in the form of Marketing Consultants from its single location in Massachusetts. 1 to 4 employees work for International Drug Development Institute Usa Inc, and the business now earns $100.000 to $499.999 per annum.

International Drug Development Institute Usa Inc was launched in 2001 and is classified under SIC code and category 8742 , and NAICS number and grouping 541613 . To contact International Drug Development Institute Usa Inc, please call Dr Marc Buyse with the phone number (617) 349-3600 or visit its single location at 185 Alewife Brook Parkway # 41 in Cambridge, Massachusetts 02138.

The location of the single location can also be found using the coordinates 42.391062,-71.141619. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.